Metformin as initial oral therapy in type 2 diabetes

JAMA - Journal of the American Medical Association

Volumn 313, Issue 24, 2015, Pages 2484-2485

  Stern, Rachel J ^a   Murphy, Elizabeth J ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; DISEASE ASSOCIATION; DRUG COST; DRUG EFFICACY; DRUG INDICATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; PROPENSITY SCORE; QUALITY OF LIFE; RETROSPECTIVE STUDY; DIABETES MELLITUS; FEMALE; MALE; PATIENT CARE; PRESCRIPTION; STATISTICS AND NUMERICAL DATA;

DIABETES MELLITUS; DRUG PRESCRIPTIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; PATIENT-CENTERED CARE;

EID: 84932083386     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.2765     Document Type: Note

References (8)

1. Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK. Use of antidiabetic drugs in the US, 2003-2012. Diabetes Care. 2014;37(5):1367-1374.
2. Bennett WL, Maruthur NM, Singh S, et al. Comparative effectiveness and safety of medications for type 2 diabetes. Ann Intern Med. 2011;154(9):602-613.
3. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006;29(8):1963-1972.
4. Garber AJ, Abrahamson MJ, Barzilay JI, et al American Association of Clinical Endocrinologists. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013;19(2):327-336.
5. Berkowitz SA, Krumme AA, Avorn J, et al. Initial choice of oral glucose-lowering medication for diabetes mellitus. JAMA Intern Med. 2014;174(12):1955-1962.
6. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease. JAMA. 2014;312(24):2668-2675.
7. Eurich DT, McAlister FA, Blackburn DF, et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure. BMJ. 2007;335(7618):497.
8. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus. Endocr Pract. 2009;15(6):540-559.